119 related articles for article (PubMed ID: 35818918)
1. Relation of beclin-1 and bcl-2 expressions with pathological parameters and prognosis in clear cell renal cell carcinomas.
Girgin RB; Ozkanli S; Engin-Zerk P; Soylemez T; Olgun ZC; Yildirim A; Kir G
Arch Esp Urol; 2022 May; 75(4):368-374. PubMed ID: 35818918
[TBL] [Abstract][Full Text] [Related]
2. Expression pattern of autophagy-related markers in non-metastatic clear cell renal cell carcinoma: association with disease recurrence following radical nephrectomy.
Nishikawa M; Miyake H; Liu B; Fujisawa M
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1585-91. PubMed ID: 25638048
[TBL] [Abstract][Full Text] [Related]
3. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
4. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population.
Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J
Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544
[TBL] [Abstract][Full Text] [Related]
5. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
8. Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters.
Baspinar S; Bircan S; Yavuz G; Kapucuoglu N
Pathol Res Pract; 2013 Jul; 209(7):418-23. PubMed ID: 23722017
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
Jung M; Lee C; Park JH; Moon KC
Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens.
Minardi D; Lucarini G; Milanese G; Montironi R; Di Primio R
Virchows Arch; 2017 Jul; 471(1):99-105. PubMed ID: 28488170
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
[TBL] [Abstract][Full Text] [Related]
12. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
13. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma.
Kim B; Jung M; Moon KC
Dis Markers; 2019; 2019():1342161. PubMed ID: 31481981
[TBL] [Abstract][Full Text] [Related]
15. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
[TBL] [Abstract][Full Text] [Related]
16. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN CONVENTIONAL RENAL CELL CARCINOMA.
Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
Georgian Med News; 2015 Dec; (249):27-33. PubMed ID: 26719546
[TBL] [Abstract][Full Text] [Related]
17. Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma.
Deng Q; Wang Z; Wang L; Zhang L; Xiang X; Wang Z; Chong T
Jpn J Clin Oncol; 2013 Dec; 43(12):1261-8. PubMed ID: 24186908
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.
Tatli Dogan H; Kiran M; Bilgin B; Kiliçarslan A; Sendur MAN; Yalçin B; Ardiçoglu A; Atmaca AF; Gumuskaya B
Diagn Pathol; 2018 Aug; 13(1):60. PubMed ID: 30144808
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Percentage Necrosis in Clear Cell Renal Cell Carcinoma.
Syed M; Loya A; Hameed M; Akhtar N; Mushtaq S; Hassan U
Am J Clin Pathol; 2022 Mar; 157(3):374-380. PubMed ID: 34643216
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
